Catalent Invests $130 Million to Add Additional Manufacturing Capacity at its Gene Therapy Campus in Harmans, Maryland
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...
DCGI nod to Serum-Oxford covid-19 vaccine for phase 2, 3 clinical trials in India
India’s top drug regulator– Drugs Controller General of India (DCGI) has granted permission to Serum Institute of India (SII) to conduct phase 2 and...
Natoli NP-RD30 Included at Diosna ProcessLab
The Diosna Dierks & Söhne GmbH recently opened the “Diosna ProcessLab” located in Osnabrück, Germany. The lab, which was completed in April 2020, offers...
OncoImmune, Inc. Raises $56 Million Series B Financing for Novel Cancer and COVID-19 Therapeutics
OncoImmune, Inc. announced the completion of a $56 million financing in Series B equity co-led by HM Capital and a blue-chip investor. Existing investors,...
Sharp launches Clinventory Inventory Management System (IMS) for clinical trials
Sharp – part of UDG Healthcare plc, a global leader in contract packaging clinical supply services, has launched a new Inventory Management System (IMS)...
Blueprint and Roche Take on Lilly As FDA Approves RET-Targeting Lung Cancer Drug
Cancer drugs firm Blueprint Medicines has gained a second US approval, with its Gavreto (pralsetinib) daily pill that targets non-small cell lung cancer with...
RECOVERY COVID-19 Phase 3 Trial to Evaluate Regeneron’s REGN-COV2 Investigational Antibody Cocktail in the UK
Regeneron Pharmaceuticals, Inc. and the University of Oxford announced that RECOVERY (Randomised Evaluation of COVid-19 thERapY), one of the world’s largest randomized clinical trials...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...